Retractable Technologies (NYSEAMERICAN:RVP) announced its earnings results on Tuesday. The company reported ($0.01) earnings per share for the quarter, Bloomberg Earnings reports. Retractable Technologies had a negative net margin of 0.64% and a negative return on equity of 3.58%. The firm had revenue of $7.67 million during the quarter.
NYSEAMERICAN RVP opened at $0.89 on Thursday. Retractable Technologies has a 12 month low of $0.89 and a 12 month high of $0.89.
About Retractable Technologies
Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare industry in the United States and internationally. Its principal products comprise VanishPoint 0.5mL insulin syringes; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; EasyPoint needles; VanishPoint blood collection tube holders; VanishPoint IV safety catheters; small diameter tube adapters; allergy trays; Patient Safe syringes; Patient Safe Luer caps; and VanishPoint blood collection sets, as well as VanishPoint autodisable syringes.
Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.